DOCSLIB.ORG

Annual Report 2008-09 Annual Report 2008-09 Qimr Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2008-09 Annual Report 2008-09 Qimr Annual Report ANNUAL REPORT 2008-09 QIMR ANNUAL REPORT 2008-09 ANNUAL REPORT 2008-09 300 Herston Road, Herston QLD 4006, Australia P: (+61) 7 3362 0222 F: (+61) 7 3362 0111 www.qimr.edu.au [email protected] ABOUT US QIMR is one of Australia’s largest and most successful medical research institutes. Our researchers are investigating the genetic and environmental causes of more than 40 diseases as well as developing new diagnostics, better treatments and prevention strategies. The Institute’s diverse research program extends from tropical diseases to cancers to Indigenous health, mental health, obesity, HIV and asthma. OUR VISION Better health through medical research. OUR MISSION To prevent and cure disease through research. OUR PHILOSOPHY QIMR supports scientists who perform world-class ethical medical research aimed at improving the health and well-being of all people. 300 Herston Road, Herston QLD 4006, Australia T: 1800 993 000 E: [email protected] www.qimr.edu.au Project Manager Sarah Tennant Compilation Jann O’Keefe Editing Sarah-Jane Matthews Design Rowland OUR LOGO Graphic Support Mimi Kersting Photography Heather Matthews The QIMR logo is comprised of superimposed Tony Phillips benzene rings which symbolise one of the fundamental Published October 2009 molecular arrangements of the chemicals which make Copies can be obtained by phoning up living things. 1800 993 000 or [email protected] Online version available at www.qimr.edu.au Director – Professor Michael Good AO Deputy Director – Professor Adèle Green AC www.qimr.edu.au | [email protected] 1800 993 000 Cover Image: Close up of neuron network Inside Cover Image: Rebekah Brennan, PhD student Cellular Immunology Laboratory - Immunology Division QIMR - Annual Report 2008-2009 QIMR - Annual Report 2008-2009 CONTENTS Organisational structure 2 QIMR at a glance 4 Research highlights 6 Chairman’s report 9 Members of Council 10 Director’s report 12 Patron’s message 15 Research Divisions 16 Genetics and Population Health 18 Immunology 34 Cancer and Cell Biology 47 Infectious Diseases 59 Joint Research 74 Corporate Division 80 Trust report 90 Members of Trust 91 Postgraduate training 96 World-class Completed students 98 Student awards 99 ethical medical research aimed Awards 100 Grants and funding 103 at improving Publications 106 the health and Lectures 130 well-being of Staff 141 all people Research students 150 Acronyms 152 QIMR - Annual Report 2008-2009 • 1 Administrative Support ORGANISATIONAL STRUCTURE General Manager Corporate Services Scientifi c Services External Relations Building Services Administrative Support Systems Implementation Stores Science Communication Safety Regulatory Affairs Purchasing Animal Welfare Graphic Support Business Development Flow Cytometry Fundraising Human Resources Glassware Services Business Services Q-Gen Histotechnology Records & Information DNA & Peptide Facility Culture & Information Technology Media Services Finance Animal Facility Grants Operational Services Transgenic Breeding Experimental Holding 2 • QIMRQIMMRM - AnnualAnnnnnual Report 2008-20092008-200 DEPUTY DIRECTOR DIRECTOR Assistant Strategic Science Director Committee (Advisory) Assistant Clinical & Translational Research Committee Director (Advisory) Senior Executive Team (Advisory) Infectious Diseases Immunology Cancer & Cell Biology Genetics & Population Mental Health Research Bacterial Vaccines Cellular Immunology Iron Metabolism Cancer Genetics Mental Health Research Malaria Drug Resistance Molecular Vaccinology Leukaemia Foundation Indigenous Health Cancer & Population Malaria Biology Immunology & Infection QCF Transgenics Studies Clinical Protein Discovery Centre Immunohaematology Signal Transduction Oncogenomics HIV Molecular Virology Molecular Immunology Molecular Pathology Molecular Psychiatry Bone Marrow Radiation Biology Parasite Cell Biology Transplantation & Oncology Genetic Epidemiology Infl ammatory Bowel RBWH Foundation Disease Scabies Tumour Immunology Conjoint Gastroenterology Molecular Epidemiology Helminth Biology Dendritic Cells & Cancer Drug Discovery Group Neurogenetics Clinical Tropical Medicine EBV Biology Hepatic Fibrosis Gynaecological Cancer Group Molecular Parasitology Cancer Immunotherapy Membrane Transport Molecular Cancer Epidemiology Mosquito Control Immunovirology Familial Cancer Molecular Genetics Qld Statistical Genetics Bacterial Pathogenesis Cancer Control Group EBV Molecular Biology Skin Cancer Carcinogenesis Epigenetics QIMRQIMR - Annual Report 2008-2009 • 3 QIMR AT A GLANCE Supporting scientists who perform world-class medical research aimed at improving the health and well-being of all people. PATENT PORTFOLIO BY CATEGORY RESEARCH AGREEMENTS New treatment patents Research service agreements Vaccine patents Clinical trial agreements Delivery platform patents Commercialisation agreements Diagnostic patents Intellectual property agreements Drug target patents License agreements Others QIMR COMPETITIVE GRANT REVENUE 2000-2009 – FUNDING RECEIVED/AWARDED $ Millions 60 50 Other granting bodies 40 The Atlantic Philanthropies Queensland Cancer Fund 30 National Institutes of Health 20 National Health and Medical Research Council 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 4 • QIMR - Annual Report 2008-2009 SCIENTIFIC PUBLICATIONS 450 400 350 300 250 200 150 100 50 2005 2006 2007 2008 2009 NHMRC FUNDING COMMUNITY SUPPORT $ Millions $ Millions 20 8.0 18 7.0 16 14 6.0 12 5.0 10 4.0 8 3.0 6 4 2.0 2 1.0 2005 2006 2007 2008 2009 2004/05 2005/06 2006/07 2007/08 2008/09 Grants Fellowships and scholarships Donations & Gifts Sponsorship Event Revenue Bequests/Gifts in Kind STAFF NUMBERS 600 500 400 300 200 100 2005 2006 2007 2008 2009 Staff Students QIMR - Annual Report 2008-2009 • 5 RESEARCH HIGHLIGHTS • Clinical trials begin for a vaccine to combat one of the world’s biggest disease killers – the Group A Streptococcus (GAS) bacteria. • Donor antigen presenting cells found to cause graft versus host disease in bone marrow transplantation patients. • The genetic risk of schizophrenia found to be the result of thousands of common genetic variations common to schizophrenia and bipolar disorder. • Identifi ed four new arboviruses from Antarctica. • Mapped the major chromosomes of Giardia duodenali; a common parasite that is often contracted from untreated water sources causing diarrhoea and vomiting. • Mapped the genome of Schistosoma japonicum; the fi rst fl atworm to be mapped. • Mitigated dengue risk in areas in southern Vietnam through the use of community based, biological control interventions to control the number of dengue spreading mosquito larvae. • Showed that the bacteria Wolbachia effectively shortens the life cycle of the mosquito Aedes aegypti, preventing it from spreading dengue fever. • Identifi ed elevated serum hyaluronic acid levels as a new diagnostic marker for the detection of cirrhosis in patients with haemochromatosis, removing the need for liver biopsy in 60% of patients. 6 • QIMR - Annual Report 2008-2009 CANCER RELATED RESEARCH HIGHLIGHTS • Contributed to the development of a topical treatment for skin cancer by demonstrating the anti cancer properties of PEP005, found in the common radium weed. • Identifi ed the reason women with BRCA1 gene expression are at a higher genetic risk of developing breast cancer. • Identifi ed two gene variants that double the risk of developing melanoma. • Discovered women who eat a diet high in fats, processed and red meats may be at an increased risk of ovarian cancer. • Demonstrated that year-round regular sunscreen use for prevention of skin cancers produces cost savings for health providers in Australia. • Showed that a diet characterised by relatively low intakes of meat, fried foods and full-fat dairy products halved the risk of developing new cutaneous squamous cell carcinomas (SCC). • Found the combined effect of obesity, acid refl ux and smoking increased the risk of developing oesophageal cancers. • Identifi ed additional breast cancer susceptibility genes through genome wide studies. QIMRQIMIMR - AnnualAnnual Report 2008-2009 • 7 AWARDS AND ACHIEVEMENTS • Professor Emma Whitelaw, Senior Principal Research Fellow, received one of only 12 Australia Fellowships which will provide a $4 million injection of funding to further her research in the fi eld of epigenetics. • Professor Dave Kemp, Head of QIMR’s Scabies Laboratory, was awarded the Order of Australia Medal in recognition of his service to medical research as a molecular biologist, particularly in the area of tropical health and infectious diseases, and for contributions to Indigenous health. • Professor Michael Good completed three years as Chairman of the NHMRC Council. • Former QIMR Director, Professor Lawrie Powell awarded the 2008 Distinguished Achievement Award of the American Association for the Study of Liver Diseases. He is the only Australian ever to receive the award and only the third recipient outside the USA in 53 years. • Dr Stuart Macgregor awarded the 2009 Premier’s Award for Health and Medical Research. • Professors Adèle Green, Peter Parsons, Nick Hayward and Associate Professors Penny Webb and David Whiteman’s NHMRC Program Grant selected by the NHMRC for their 2008 list of “10 of the Best”. • Marina Kvaskoff received the 2008 L’Oreal France- UNESCO Women in Science Award. • QIMR’s fi rst Indigenous cadet, Lisa Whop successfully completed a Bachelor Applied Science (Medical Science) at the Queensland University of Technology. • Ms Lorna Lane, Corporate Division, awarded the Bancroft Medal for an outstanding
Load more

Recommended publications
  • The John Curtin School of Medical Research Annual Review 2012
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH ANNUAL REVIEW 2012 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2012 From the Director 3 The John Curtin School of Medical Organisation Chart 4 Research Committees 5 COMMUNITY 7 Official Opening of Stage 3 8 Launch of The John Curtin Medical Research Foundation 9 Professor Gordon Ada 10 Open Day 11 Community Activities 12 RESEARCH IN REVIEW 2012 15 Eccles Institute of Neuroscience 16 Department of Genome Biology 29 Department of Immunology 36 Department of Pathogens and Immunity 45 Department of Molecular Bioscience 47 Department of Translational Medicine 56 Australian Phenomics Facility 60 Biomolecular Resource Facility/Genome Discovery Unit 61 STAFF AND STUDENT ACHIEVEMENTS 63 VISITORS AND COLLABORATIONS 69 STAFF AND STUDENTS 85 Department of Genome Biology 86 Department of Immunology 87 Eccles Institute of Neuroscience 88 Department of Pathogens and Immunity 90 Department of Molecular Bioscience 90 Department of Translational Medicine 92 APF and Animal Services 92 School Services 94 School Administration 95 Students 96 PUBLICATIONS, PRESENTATIONS AND COMMUNITY OUTREACH 99 SUPPORT 129 Grants 130 Financial Overview 134 Donors 135 Sponsors 136 Annual Review 2012 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Zinkernagel. He will be sadly missed by his many friends and colleagues at the School, who have established the annual Gordon Ada New Investigator Award in his memory. In 2012, we finally completed the long and very necessary redevelopment project that resulted in the new John Curtin School of Medical Research building on the ANU campus. All our staff and students are once again under one roof, carrying out their research in state of the art laboratories and facilities.
    [Show full text]
  • Understanding Genomics
    Predict Diagnose Treat Understanding genomics A comprehensive guide brought to you by Garvan. Contents What is genomics? 4 A short history of DNA 5 Genomics information for a lifetime 7 Conversations about genomics 11 How does genome sequencing work? 12 Can I have my genome sequenced? 13 Genomics research at Garvan 14 Garvan’s genomics research programs 18 Genomics research centres 20 Useful terms 22 Predict Diagnose Treat 2 3 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research in Sydney. I wanted to introduce myself and thank you for your interest in understanding genomics. Genomics is the study of genes and other information encoded in an individual’s genome—the complete set of instructions in their DNA. Each person has different DNA, unique just to you. Every disease has a genetic component. Through genomics research, we can further understand what our genetic information – and our gene or genetic variations – mean for our health. Garvan scientists use genomics research to understand more about disease and determine how to best diagnose, treat and prevent it. I hope you find this brochure informative and useful and consider joining our family, pioneering the future of medical research. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 2 3 What is genomics? Genomics is the study of your genome – all the information encoded in your DNA.
    [Show full text]
  • INTERVIEW with PAUL DURBIN Mccurry Interviewed by Betty J. Blum Compiled Under the Auspices of the Chicago Architects Oral Histo
    INTERVIEW WITH PAUL DURBIN McCURRY Interviewed by Betty J. Blum Compiled under the auspices of the Chicago Architects Oral History Project The Ernest R. Graham Study Center for Architectural Drawings Department of Architecture The Art Institute of Chicago Copyright © 1988 Revised Edition Copyright © 2005 The Art Institute of Chicago This manuscript is hereby made available to the public for research purposes only. All literary rights in the manuscript, including the right to publication, are reserved to the Ryerson and Burnham Libraries of The Art Institute of Chicago. No part of this manuscript may be quoted for publication without the written permission of The Art Institute of Chicago. ii TABLE OF CONTENTS Preface iv Preface to the Revised Edition vi Outline of Topics vii Oral History 1 Selected References 150 Curriculum Vitae 151 Index of Names and Buildings 152 iii PREFACE On January 23, 24, and 25, 1987, I met with Paul McCurry in his home in Lake Forest, Illinois, where we recorded his memoirs. During Paul's long career in architecture he has witnessed events and changes of prime importance in the history of architecture in Chicago of the past fifty years, and he has known and worked with colleagues, now deceased, of major interest and significance. Paul retains memories dating back to the 1920s which give his recollections and judgments special authority. Moreover, he speaks as both an architect and an educator. Our recording sessions were taped on four 90-minute cassettes that have been transcribed, edited and reviewed for clarity and accuracy. This transcription has been minimally edited in order to maintain the flow, spirit and tone of Paul's original thought.
    [Show full text]
  • Durham E-Theses
    Durham E-Theses Health in urban late medieval North-West Europe: a bioarchaeological study of Caen, Canterbury and Ghent GERNAY, MARIEKE,JOSY,CHANTAL How to cite: GERNAY, MARIEKE,JOSY,CHANTAL (2015) Health in urban late medieval North-West Europe: a bioarchaeological study of Caen, Canterbury and Ghent, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/11433/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 Abstract Health in urban late medieval North-West Europe: a bioarchaeological study of Caen, Canterbury and Ghent M.J.C. Gernay Over half of the global population currently lives in an urban environment and this is still increasing rapidly in developing countries. This thesis aims to provide a comparative picture of health in the rapidly developing urban centres in late medieval NW Europe - here defined as northern France, England and Belgium - through bioarchaeological analysis.
    [Show full text]
  • Annual Report (March 2010-February 2011)
    EMBL Australia Annual Report [March 2010 – February 2011] 2 EMBL AUSTRALIA ANNUAL REPORT 2009–10 Contents Chairman’s report 2 Scientific Head’s report 3 About EMBL Australia 4 The European Molecular Biology Laboratory 4 2010 Highlights 5 2011 Outlook 6 Key activities 7 Launch by Minister Carr 7 Appointment of Scientific Head 8 EBI Mirror Facility and the National Bioinformatics Network 8 EBI Mirror at The University of Queensland 8 EMBL Australia Bioinformatics Network 9 International PhD Program 9 Partner Laboratory Network 9 Appointment of Edwina McGlinn 10 Appointment of Nicolas Platcha 11 Faculty Development Program 11 Sponsorship of BioInfoSummer 11 Governance 12 EMBL Australia participant expansion 12 Council 12 Appointment of new members 12 Council Members 12 Meetings 12 Planning and Finance Committee 13 Members 13 Meetings 13 Bioinformatics Committee 13 Members 13 Meetings 13 Staff 14 Australian visitors to EMBL 2010 15 Visitors to EMBL Australia 15 Financial report 16 Documents and Media releases 18 Funding & Stakeholders 20 Participants 20 Funding and in-kind support 20 Contact details inside back cover 1 Chairman’s report 2010 was a seminal year in the EMBL Australia initiative. Our official launch by Minister Carr in March coincided with the announcement of several key developments. These developments included the appointments of our Scientific Head and first Partner Laboratory Group Leaders, along with the announcement of a second node and associated national network for bioinformaticians. EMBL Australia’s participation is set to expand, with invitations accepted by the remaining Go8 universities to join EMBL Australia. This will extend direct involvement to a wider group of research institutions and expand the potential reach of EMBL Australia programs.
    [Show full text]
  • June 06.Indd
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 June 2006 Overview of the JCSMR Immunogenomics Laboratory 2006 Gerard Hoyne Overview they were able to reveal that the autoimmune but Dr Horikawa, a postodoctoral fellow in The Immunogenomics Laboratory at the regulator gene AIRE, which is expressed by the lab, has made the remarkable fi nding that John Curtin School of Medical Research in a subset of thymic epithelial cells, plays a the exact opposite is the case. The memory Canberra comprises four research groups critical role in establishing T cell tolerance B cell receptor is less active at inducing a working in concert to develop an integrated to self antigens in the thymus. In addition, subset of genes, and in this case less signal understanding of how our immune system is Adrian also identifi ed that defective signals means more antibody formation. controlled at the cellular and molecular level to cell death genes account for the inherited by circuits that are specifi ed in our genome resistance of T lymphocytes to clonal deletion Carola Vinuesa heads the Humoral sequence. Each of the groups focuses on in the thymus of NOD mice. Upon infection memory and Autoimmunity Group. a different element of a fundamental set with a virus or bacteria, B lymphocytes with Her group is investigating the cellular and of immune system decisions made at the the right antigen receptors to neutralize molecular events that regulate production level of individual immune system cells: infection are stimulated to switch the isotype and selection versus elimination of memory either to fi ght or to disarm.
    [Show full text]
  • AB O UT NABAT BOO KS NABAT BOOKS Is a Series
    ABOUT NA BAT BOOKS NABAT BOOKS is a series dedicated to reprinting forgotten mem­ oirs by various misfits, outsiders, and rebels. The underlying concept is based on a few simple propositions: That to be a success under the current definitionis highly toxic - wealth, fame and power are a poison cocktail; that this era of tri­ umphal capitalism glorifies the most dreary human traits like greed and self-interest as good and natural; that the "winners" version of reality and history is deeply lame and soul-rotting stuff Given this, it follows thatthe truly interesting and meaningfullives and real adven­ tures are only to be had on the margins of what Kenneth Rexroth called "the social lie". It's with the dropouts, misfits, dissidents, rene­ gades and revolutionaries, against the grain, between the cracks and amongst the enemies of the state that the good stuffcan be found. Fortunately there is a mighty subterranean river of testimony fromthe disaffected, a large cache of hidden history, of public secrets over­ looked by the drab conventional wisdom that Nabat books aims to tap into. A little something to set against the crushed hopes, mountains of corpses, and commodification of everything. Actually, we think, it's the best thing western civilization has going foritself . BEGGARS OF LIFE A Hobo Autobiography OTHER BOOKS IN THE NABAT SERIES You Can't W'in- Jack Black Sister Of The Road· The Autobiography of Boxcar Bertha - Ben Reitman BAD: The Autobiography ofJames Carr - James Carr Memoirs ofVidocq: Master of Crime - Franc;:ois Eugene Vidocq Beggars of Life - Jim Tully Out of the Night - Jan Val tin BEGGARS OF LIFE A HOBO AUTOBIOGRAPHY JIM TULl..Y INTRODUCTION BY CHARLES WILLEFORD AK PRESS I NABAT EDINBURGH, LONDON, l=lND OAKLAND 2004 This edition copyright© 2004 Nabat/AK Press 1st Nabat Edition First published 1924 by Albert & Charles Boni Holistic Barbarian Reprinted by permission of JET Literary Associates, Inc.
    [Show full text]
  • THE JOHN CURTIN SCHOOL of MEDICAL RESEARCH Annual Review 2013
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH Annual Review 2013 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2013 The John Curtin School of Medical Research From the Director 3 Staff and student lists 87 Department of Genome Biology 88 Organisation Chart 4 Department of Immunology 90 Committees 5 Eccles Institute of Neuroscience 92 Department of Molecular Bioscience 94 Community 7 Department of Translational Medicine 96 Department of Pathogens and Immunity 96 Centenary of Canberra 2013 Australian Phenomics Facility 97 14th Frank and Bobbie Fenner Conference 8 School Administration 98 The John Curtin Medical Research Foundation Dinner 9 School Services 98 David Curtis Reading Room 10 The ACRF Biomolecular Resource Facility Open Day 2013 11 and Genome Discovery Unit 99 Community Activities 12 Students 100 Research in Review 2013 15 Publications, presentations and Eccles Institute of Neuroscience 16 community outreach 103 Department of Genome Biology 30 Publications 104 Department of Immunology 38 Staff Presentations 110 Department of Pathogens and Immunity 48 Student Presentations 117 Department of Molecular Bioscience 52 Community Outreach 121 Department of Translational Medicine 58 Australian Phenomics Facility 60 Support to JCSMR 131 The Imaging and Cytometry Facility 62 Grants 132 The ACRF Biomolecular Resource Facility Financial Overview 136 and Genome Discovery Unit 63 Donors 137 Staff and student achievements 65 Sponsors 138 Graduates 66 Prizes and Awards 67 Visitors and collaborations 71 Visitors 72 Collaborations 74 Annual Review 2013 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Following the opening of Stage 3 of our new building in 2012, JCSMR staff and students have enjoyed the opportunities provided by the new spaces, including the laboratories, and meeting rooms such as the Science Forum.
    [Show full text]
  • ART DECO and BRAZILIAN MODERNISM a Dissertation
    SLEEK WORDS: ART DECO AND BRAZILIAN MODERNISM A Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University in partial fulfillment of the requirement for the degree of Doctor in Philosophy in Spanish By Patricia A. Soler, M.S. Washington, DC January 23, 2014 Copyright by Patricia A. Soler All rights reserved ii SLEEK WORDS: ART DECO AND BRAZILIAN MODERNISM Patricia A. Soler, M.S. Thesis advisor: Gwen Kirkpatrick, Ph.D. ABSTRACT I explore Art Deco in the Brazilian Modernist movement during the 1920s. Art Deco is a decorative arts style that rose to global prominence during this decade and its proponents adopted and adapted the style in order to nationalize it; in the case of Brazil, the style became nationalized primarily by means of the application of indigenous motifs. The Brazilian Modernists created their own manifestations of the style, particularly in illustration and graphic design. I make this analysis by utilizing primary source materials to demonstrate the style’s prominence in Brazilian Modernism and by exploring the handcrafted and mechanical techniques used to produce the movement’s printed texts. I explore the origins of the Art Deco style and the decorative arts field and determine the sources for the style, specifically avant-garde, primitivist, and erotic sources, to demonstrate the style’s elasticity. Its elasticity allowed it to be nationalized on a global scale during the 1920s; by the 1930s, however, many fascist-leaning forces co- opted the style for their own projects. I examine the architectural field in the Brazil during the 1920s.
    [Show full text]
  • 2019 Annual Report
    Annual Report 2019 Garvan Institute of Medical Research Annual Report 2019 2019 Strength through collaboration Our vision Our values We see a future where everyone lives a longer, healthier life. Excellence Our mission Innovation We will harness all the information encoded in the genome Collaboration to better diagnose, predict, treat and prevent diseases that have the deepest impact on society. Community Integrity Respect Who we are, what we do The Garvan Institute of Medical Research brings together world-leading clinicians and basic and translational researchers. We are patient focused. Our researchers break down barriers between traditional scientific disciplines to find solutions to disease. Founded in 1963, Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and developed treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity. Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease. Garvan’s research has global impact. World-leading people pioneer discoveries across four intersecting research themes. We lead the field in medical genomics, epigenetics, and cellular genomics; cancer; diseases of immunity and inflammation; and diseases of ageing affecting bone, brain and metabolism. Our goal is to translate discovery into meaningful health benefits for those living with disease and their family. Patients, clinical trial cohorts and population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact.
    [Show full text]
  • 2018 Annual Report 2018 Our Year of Big Thinking, Collaboration and Discovery
    2018 Annual Report 2018 Our year of big thinking, collaboration and discovery. Our vision Our values We see a future where everyone lives a longer, Excellence healthier life. Innovation Our mission Collaboration We will harness all the information encoded in Community the genome to make pioneering discoveries that Integrity predict, treat and prevent diseases that have the deepest impact on society. Respect 2018 Garvan Annual Report Our values Who we are, what we do Aspirations Excellence Garvan is leading the nation in using genomic analysis • To become the most advanced institute in the to accelerate discovery and enable personalised, region in the adoption, application and integration Innovation precision medicine. of next-generation genomic and computational approaches and technologies in investigative and Collaboration Our researchers pioneer studies into some of the most translational research. difficult to solve and widespread diseases affecting the Community community today. Garvan is focused on understanding • To advance knowledge in our key areas of critical the molecular and cellular processes in health and mass that will lead to better understanding, reduced Integrity disease, putting people and patients at the centre of incidence and improved treatments for cancer, leading-edge local and global research expertise and immune deficiency, inflammatory and autoimmune Respect networks as the basis for developing future preventions diseases including diabetes, osteoporosis, and and treatments. diseases of ageing affecting the brain and other organs. For 56 years, Garvan scientists have been achieving significant breakthroughs in the understanding and • To attract, develop and support exceptionally talented treatment of diseases. researchers with leading-edge programs addressing key conceptual and practical questions in human biology, and the translation of new knowledge and technologies into clinical applications.
    [Show full text]
  • 2017 Annual Report GARVAN INSTITUTE of MEDICAL RESEARCH MISSION and VISION
    BREAKTHROUGH MEDICAL RESEARCH 2017 Annual Report GARVAN INSTITUTE OF MEDICAL RESEARCH MISSION AND VISION To make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human Respect Passion health. Garvan’s ultimate goal is prevention and treatment of major diseases. Collaboration Values Excellence Innovation Integrity Who we are, Aspirations • To attract, develop and support exceptionally talented what we do • To become the most researchers with leading‑edge advanced institute in the programs addressing key Garvan is leading the nation region in the adoption, conceptual and practical in using genomic analysis to application and integration of questions in human biology, accelerate discovery and enable next‑generation genomic and and the translation of new personalised, precision medicine. computational approaches and knowledge and technologies technologies in investigative into clinical applications. Our researchers pioneer and translational research. studies into some of the most • To embrace and uphold a culture widespread diseases affecting • To advance knowledge in our of collegiality, collaboration, the community today. Garvan is key areas of focus that will inclusivity, consideration, focused on understanding the lead to better understanding, safety, transparency, and role of molecular and cellular reduced incidence and high ethical standards. processes in health and disease improved treatments for cancer, as the basis for developing future osteoporosis, diabetes, obesity, • To engage stakeholders preventions and treatments. and immunological, skeletal and and the community with our neurological diseases, and achievements and research For 55 years, Garvan to influence health policy. vision so that we attract the scientists have been achieving significant government and significant breakthroughs donor support needed in the understanding and to empower our treatment of diseases.
    [Show full text]